FinMedium

A Community Sourced Financial Web Magazine

Skip to content
Menu
  • Home
  • Categories
    • FinMedium Research Desk
    • Sectors
    • Educational
    • Concall Summaries
    • Investing
    • Decision Making
    • Financial Planning
    • Book Summaries
    • Companies
    • Mutual Funds
  • हिन्दी
  • Submit Article
  • Contributors
  • Important Links
    • About FinMedium
    • Terms of Use & Privacy Policy

Category: marksanspharmaanalysis

Marksans Pharma Ltd-Q3FY21 Analysis
company manufacturing soft gel capsules in India

Marksans Pharma Ltd-Q3FY21 Analysis

Posted on February 20, 2021 by Shekhar Yadav

Reading Time: < 1 minute Q3FY21 was the best ever quarter in terms of both revenue and profitability, much like all other companies. In terms of revenue, while the quarter…

Marksans Pharma Ltd- Analysis
advantagesofsoftgelcapsules

Marksans Pharma Ltd- Analysis

Posted on September 5, 2020 by Shekhar Yadav

Reading Time: < 1 minute Since the company largely manufactures in India and export its exports via its subsidiaries, it would be more meaningful to look at the consolidated numbers.…

What is FinMedium?

FinMedium is a financial web-magazine that publishes the insightful and sharp ideas of the financial thinkers and writers.

Our mission is to help people make wise decisions on the matters that matter the most – Finances.

Disclaimer

The blog posts on FinMedium must not be construed as an investment advice either from FinMedium or Author.

© Copyright 2021 – FinMedium
Wisteria Theme by WPFriendship ⋅ Powered by WordPress